GSK232
GSK232 is a highly selective, cellularly penetrant CECR2 inhibitor with excellent physicochemical properties.
Product Specifications
CAS Number
2702984-69-6
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gsk232.html
Solubility
10 mM in DMSO
Smiles
O=S(C(C=C1NC(CN2C3=C(CN(CC3)C)N=N2)=O)=C(C=C1)Cl)(N4C[C@@](C5CC5)([H])CC4)=O
Molecular Formula
C21H27ClN6O3S
Molecular Weight
479.00
References & Citations
[1]Lucas SCC, et al. Optimization of Potent ATAD2 and CECR2 Bromodomain Inhibitors with an Atypical Binding Mode. J Med Chem. 2020 May 28;63 (10) :5212-5241.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PJB29662-01 50 mg
4- (1,1-Dioxo-1,2-thiazolidin-2-yl) -3-methylbenzoic acid
Sign In for Pricing
View Details PJB29662-02 0.5 g
4- (1,1-Dioxo-1,2-thiazolidin-2-yl) -3-methylbenzoic acid
Sign In for Pricing
View Details 
032619-ML550 100 µL
BTN2A1, CT (BTN2A1, BT2.1, BTF1, Butyrophilin subfamily 2 member A1) (MaxLight 550) discontinued
Sign In for Pricing
View Details 